A profitable, low-beta Virginia community bank screens as a factor-value candidate: forward P/E near 10x, P/TBV near 1.2x, strong H1 2026 earnings momentum and a signed Eagle Financial merger that could lift 2027 EPS. The upside is real but not huge; the thesis now depends on clean approvals, TBV-dilution earnback and credit quality through a CRE-heavy regional-bank cycle.
multiple path is observable peers -> median context -> numeric adjustments -> fair value. Peer forward P/E range used here is roughly 10.3x-13.5x; base FV implies 1.31x BVPS and roughly 12.8x estimated 2026 EPS, under the $27 consensus and close to the latest $26 KBW target dated 2026-09-14. Cross-check: $1.95 estimated 2026 EPS x 13.0x = $25.35, within 1% of the $25.50 bridge. Sensitivity: every +/-0.10x on P/TBV moves value by about +/-$1.94 per share. Not investment advice.
| Component | Assumption | USD/share |
|---|---|---|
| Standalone tangible book anchor | Q2 2026 book value per share $19.40 x 1.00x baseline bank TBV | +19.40 |
| Quality / franchise premium | $19.40 BVPS x 0.18x premium for 1.20% ROAA and low 0.42 beta | +3.49 |
| Eagle EPS accretion option | $1.72 TTM EPS x 38% stated 2027E accretion x 10.5x x 50% realization | +3.43 |
| Dividend and buyback carry | $0.40 annualized dividend plus active repurchase authorization through 2027-08-31 | +0.40 |
| Deal dilution / execution reserve | -$19.40 BVPS x 6.3% risk reserve vs stated ~14% close TBV dilution | -1.22 |
| FV base case | Explicit sum: 19.40 + 3.49 + 3.43 + 0.40 - 1.22 | 25.50 |
Insider ownership is meaningful at about 12.7%. No material class-action, short-seller report, SEC investigation, or large insider-sale controversy was identified in the current source review; the main governance item is the pending merger vote and related proxy process.
| Item | FY2023 | FY2024 | FY2025 | TTM Jun 2026 | Guidance / read-through |
|---|---|---|---|---|---|
| Revenue ($M) | 38.8 | 53.7 | 61.0 | 66.9 | Positive operating leverage in Q2 2026 |
| Net income ($M) | 5.1 | 17.1 | 21.2 | 24.3 | Q2 2026 net income +37.5% YoY |
| EPS ($) | 0.36 | 1.20 | 1.49 | 1.72 | StockAnalysis TTM EPS +30.6% |
| Gross loans ($B) | 1.86 | 1.87 | 1.98 | 2.02 | Moderate loan growth; credit quality is the watch item |
| Deposits ($B) | 1.91 | 1.89 | 1.97 | 1.99 | Stable funding base, but rate sensitivity remains relevant |
| Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
| Net interest income ($M) | 14.9 | N/D | N/D | 16.5 est. | 17.3 |
| Net income ($M) | 5.1 | N/D | N/D | ~6.0 est. | 7.0 |
| EPS ($) | 0.36 | N/D | N/D | 0.43 | 0.50 |
| Book value per share ($) | 17.83 | N/D | 18.69 | N/D | 19.40 |
Business model - Northern Virginia commercial banking franchise
Commercial real estate / construction ~majority of loan economics; exact split not isolated in current source set ramping Core earnings engine and key risk bucket. Higher rates can support asset yield, but credit migration or property-value stress would re-rate the equity fast. Commercial & industrial banking relationship-led deposit and loan franchise needs deposit-cost discipline Cross-sell and treasury services should improve after the EFSI merger if integration succeeds and local bankers retain clients. Eagle Financial / Bank of Clarke pro forma ~$253M all-stock transaction; 2.00 JMSB shares per EFSI share signed, not closed Adds Virginia/Shenandoah Valley scale. Management targets large 2027 EPS accretion, but TBV dilution and approval timing are the offset. Capital return $0.40 annual dividend plus buyback authorization secondary to M&A Useful support for the value screen, but capital deployment is likely conservative until the transaction and integration are de-risked.
Legal, regulatory and risk analysis
SWOT analysis
- +Profitable bank with TTM EPS growth above 30%.
- +Low beta, low short interest and meaningful insider ownership.
- +Forward P/E near 10x gives valuation support.
- −Base upside is modest versus higher-risk small caps.
- −CRE and local deposit competition remain macro-sensitive.
- −Merger creates near-term tangible book dilution.
- →Eagle deal can increase scale and 2027 EPS if cost saves are delivered.
- →Pro forma dividend and broader branch network could improve investor visibility.
- →A clean Q3 release can validate margin momentum.
- !Regulatory or shareholder delay would push out the main catalyst.
- !Credit costs can overwhelm low multiple arguments.
- !If rates move against the deposit base, NIM and earnings estimates compress.
Summary by assessment area
- At $22.99, JMSB trades below a $25.50 base FV but the spread is only about 11%.
- Factor tag: VALUE, driven by forward P/E and tangible-book support.
- The Eagle merger is the main catalyst and the main complication.
- Monitor proxy timing, regulatory milestones and cost-save guidance.
- CET1, ROAA and book-value growth support the franchise.
- Credit quality must remain benign for the FV bridge to hold.
Sources: StockAnalysis JMSB overview/statistics/financials/history, John Marshall Bancorp Q2 2026 release and September 2026 Eagle Financial merger release, SEC S-4/proxy filed 2026-10-02, MarketBeat short-interest page, Benzinga analyst target table, StockScan price history, StockAnalysis peer statistics for FVCB/EFSI/PEBO. Market data as of 2026-10-06: JMSB current price used ~$22.99 close, market cap ~$323M, 52W range $18.50-$24.26, shares outstanding ~14.04M, short interest 1.41% of float. Price sanity check: $22.99 x 14.04M shares ~= $323M market cap, consistent with reported market cap. This document is for informational purposes only and does not constitute financial or investment advice.